Denali

DNLI NASDAQ
18.10
-0.47
-2.53%
已收盘, 16:29 08/22 EDT
开盘
18.61
昨收
18.57
最高
18.61
最低
17.71
成交量
17.61万
成交均量(3M)
31.04万
52周最高
28.87
52周最低
13.78
换手率
0.18%
市值
17.35亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Denali DNLI股票价格,Denali股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately four specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration. The Company’s development programs include Lysosomal Function Pathway, Glial Biology Pathway, and Cellular Homeostasis Pathway. Its product pipeline includes drug candidates such as DNL201, DNL 151, ATV:aSyn, ETV:IDS, DNL747, and ATV:TREM2.
展开 >

最近浏览

名称
价格
涨跌幅